| Literature DB >> 21373288 |
Heather L Crouse, Charles G Macias, Andrea T Cruz, Kim A Wilson, Susan B Torrey.
Abstract
BACKGROUND: Bateys are impoverished areas of housing for migrant Haitian sugar cane workers in the Dominican Republic (DR). In these regions, preventative health care is almost non-existent, public service accessibility is limited, and geographic isolation prevents utilization of care even by those families with resources. Consequently, the development of a viable mobile system is vital to the delivery of acute and preventative health care in this region. AIMS: This study evaluated an existing mobile medical system. The primary goal was to describe the population served, diseases treated, and resources utilized. A secondary goal was to determine qualitatively an optimal infrastructure for sustainable health care delivery within the bateys.Entities:
Keywords: Developing country; Disease prevalence; Dominican Republic; International health; Mobile medical system; Pediatric emergency medicine; Pediatrics
Year: 2010 PMID: 21373288 PMCID: PMC3047868 DOI: 10.1007/s12245-010-0198-4
Source DB: PubMed Journal: Int J Emerg Med ISSN: 1865-1372
Clinical criteria for diagnoses
| Diagnosis | Clinical criteria |
|---|---|
| Parasitic infection | History of chronic abdominal pain with diarrhea and/or severe abdominal pain, or report of worms in stool |
| Anemia | Complaint of weakness with associated scleral icterus or conjunctival pallor, nailbed pallor and tachycardia without alternative explanation defined by age-appropriate ranges |
| Asthma | History of chronic cough and wheezing at time of presentation |
| Allergies | History of clear rhinnorhea and itching or hives not associated with fever or other skin infection |
Most common acute diagnoses
| Diagnosis | Acute diagnoses made (total N = 373) | |
|---|---|---|
| Number | % (95% CI) | |
| URI | 133 | 35.6 (30.9–40.6) |
| Headache | 56 | 15.0 (11.8–19.0) |
| Skin superinfection | 47 | 12.6 (9.6–16.4) |
| Fever | 30 | 8.0 (5.7–11.3) |
| Ecthyma | 22 | 5.9 (3.9–8.8) |
| Otitis media | 20 | 5.4 (3.5–8.1) |
| Asthma exacerbation | 18 | 4.8 (3.1–7.5) |
| Dehydration | 8 | 2.1 (1.1–4.2) |
| Pharyngitis | 8 | 2.1 (1.1–4.2) |
| UTI | 7 | 1.9 (0.9–3.8) |
| Pneumonia | 4 | 1.1 (0.4–2.7) |
| Other | 20 | 5.4 (3.5–8.1) |
Most common chronic diagnoses
| Diagnosis | Chronic diagnoses made (total N = 657) | |
|---|---|---|
| Number | % (95% CI) | |
| Parasite/ameba/giardia | 331 | 50.4 (46.6–54.2) |
| Scabies | 68 | 10.4 (8.3–12.9) |
| Tinea capitus | 48 | 7.3 (5.6–9.6) |
| Symptomatic anemia | 42 | 6.4 (4.8–8.5) |
| Tinea corporis | 40 | 6.1 (4.5–8.2) |
| Allergies | 30 | 4.6 (3.2–6.4) |
| Dermatitis/eczema | 26 | 4.0 (2.7–5.7) |
| Tinea versicolor | 17 | 2.6 (1.6–4.1) |
| Failure to thrive | 8 | 1.2 (0.6–2.4) |
| Other | 47 | 7.2 (5.4–9.4) |
Diagnoses
| Category | Diagnosis | Patients receiving diagnosis (total N = 584) | |
|---|---|---|---|
| Number | % (95% CI) | ||
| GI infections | Parasites | 319 | 54.6 (50.5–58.6) |
| Ameba | 10 | 1.7 (0.9–3.1) | |
| Giardia | 2 | 0.3 (0.1–1.2) | |
| Skin infections | Scabies | 68 | 11.6 (9.2–14.5) |
| Skin superinfection | 47 | 8.0 (6.1–10.5) | |
| Ecthyma | 22 | 3.8 (2.5–5.6) | |
| Dermatitis/eczema | 26 | 4.5 (3.1–6.4) | |
| Fungal infections | Tinea capitis | 48 | 8.2 (6.3–10.7) |
| Tinea corporis | 40 | 6.8 (5.1–9.2) | |
| Tinea versicolor | 17 | 2.9 (1.8–4.6) | |
| Candida | 2 | 0.3 (0.1–1.2) | |
| ENT/pulmonary | URI | 133 | 22.8 (19.6–26.4) |
| Allergies | 30 | 5.1 (3.6–7.2) | |
| Asthma | 18 | 3.1 (2.0–4.8) | |
| Otitis media | 20 | 3.4 (2.2–5.2) | |
| General | Symptomatic anemia | 42 | 7.2 (5.4–9.6) |
| Headache | 56 | 9.6 (7.5–12.3) | |
| Fever | 29 | 5.0 (3.5–7.0) | |
| Other | 188 | 32.2 (28.5–36.1) | |
Medications givena
| Category | Medication given | Patients receiving medication (total N = 584) | |
|---|---|---|---|
| Number | % (95% CI) | ||
| GI medications | Mebendazole | 179 | 30.7 (27.0–34.5) |
| Albendazole | 150 | 25.7 (22.3–29.3) | |
| Metronidazole | 8 | 1.4 (0.7–2.7) | |
| Skin medications | Lindane | 57 | 9.8 (7.6–12.4) |
| Permethrin | 8 | 1.4 (0.7–2.6) | |
| Vaseline | 11 | 1.9 (1.1–3.3) | |
| Griseofulvin | 29 | 5.0 (3.5–7.0) | |
| Antifungal cream | 53 | 9.1 (7.0–11.7) | |
| Steroid cream | 21 | 3.6 (2.4–5.4) | |
| Antibiotics | Amoxicillin/clavunate | 29 | 5.0 (3.5–7.0) |
| Amoxicillin | 42 | 7.2 (5.4–9.6) | |
| Trimethoprim-sulfamethoxazole | 10 | 1.7 (0.9–3.1) | |
| ENT/pulmonary medications | Albuterol MDI | 5 | 0.9 (0.4–2.0) |
| Albuterol liquid | 12 | 2.1 (1.2–3.6) | |
| Diphenhydramine | 22 | 3.8 (2.5–5.6) | |
| Cetirizine | 12 | 2.1 (1.2–3.6) | |
| Prednisone | 4 | 0.7 (0.3–1.7) | |
| Over-the-counter | Acetaminophen | 80 | 13.7 (11.2–16.7) |
| Ibuprofen | 58 | 9.9 (7.8–12.6) | |
| Cold medicationa | 81 | 13.9 (11.3–16.9) | |
| Vitamins | Multivitamin | 362 | 62.0 (58.0–65.8) |
| Iron | 32 | 5.5 (3.9–7.6) | |
| Other | Other | 33 | 5.7 (4.1–7.8) |
aThis study was performed prior to the Food and Drug Adminstration warning against the use of cough suppressants in children <2 years of age